Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.

Autor: Wang AX; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California., Busque S; Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, California., Kuo J; Pharmacy Manager of Clinical Effectiveness, Department of Pharmacy, Stanford Health Care, Stanford, California., Singh U; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California., Röeltgen K; Department of Pathology, Stanford University School of Medicine, Stanford, California., Pinsky BA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Department of Pathology, Stanford University School of Medicine, Stanford, California., Chertow GM; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California., Scandling JD; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California., Lenihan CR; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California.

Publikováno v: Kidney360 [Kidney360] 2021 Oct 20; Vol. 3 (1), pp. 133-143. Date of Electronic Publication: 2021 Oct 20 (Print Publication: 2022).